Heparin inhibits pulmonary artery smooth muscle cell proliferation through guanine nucleotide exchange factor-H1/RhoA/Rho kinase/p27

American Journal of Respiratory Cell and Molecular Biology

Volumn 44, Issue 4, 2011, Pages 524-530

  Yu, Lunyin ^a   Quinn, Deborah A ^a   Garg, Hari G ^a   Hales, Charles A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Guanine nucleotide exchange factor H1; Heparin; Proliferation; Pulmonary artery smooth muscle cell; Rho kinase

Indexed keywords

COMPLEMENTARY DNA; GUANINE NUCLEOTIDE EXCHANGE FACTOR; GUANINE NUCLEOTIDE EXCHANGE FACTOR H1; HEPARIN; PROTEIN P27; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTERY MUSCLE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA TRANSFECTION; DOWN REGULATION; ENZYME REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HYPOXIA; LUNG ARTERY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER;

ANIMALS; CATTLE; CELL CYCLE; CELL HYPOXIA; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P27; GENE EXPRESSION REGULATION; GUANINE NUCLEOTIDE EXCHANGE FACTORS; GUANOSINE TRIPHOSPHATE; HEPARIN; HUMANS; MICE; MODELS, BIOLOGICAL; MYOCYTES, SMOOTH MUSCLE; PULMONARY ARTERY; RHO-ASSOCIATED KINASES; RHOA GTP-BINDING PROTEIN; RNA, SMALL INTERFERING;

MUS;

EID: 79953746692     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2010-0145OC     Document Type: Article

References (47)

1. Jaffe AB, Hall A. Rho GTPases: biochemistry and biology. Annu Rev Cell Dev Biol 2005;21:247-269.
2. Sylvester JT. The tone of pulmonary smooth muscle: ROK and Rho music? Am J Physiol Lung Cell Mol Physiol 2004;287:L624-L630.
3. Schwartz M. Rho signaling at a glance. J Cell Sci 2004;117:5457-5458.
4. Kip1 levels by distinct mechanisms. Mol Cell Biol 2006;26:4612-4627.
5. Nagaoka T, Fagan KA, Gebb SA, Morris KG, Suzuki T, Shimokawa H, McMurtry IF, Oka M. Inhaled Rho kinase inhibitors are potent and selective vasodilators in rat pulmonary hypertension. Am J Respir Crit Care Med 2005;171:494-499. (Pubitemid 40444250)
6. Nagaoka T, Gebb SA, Karoor V, Homma N, Morris KG, McMurtry IF, Oka M. Involvement of RhoA/Rho kinase signaling in pulmonary hypertension of the fawn-hooded rat. J Appl Physiol 2006;100:996-1002. (Pubitemid 43671557)
7. Guilluy C, Sauzeau V, Rolli-Derkinderen M, Guerin P, Sagan C, Pacaud P, Loirand G. Inhibition of RhoA/Rho kinase pathway is involved in the beneficial effect of sildenafil on pulmonary hypertension. Br J Pharmacol 2005;146:1010-1018. (Pubitemid 41722174)
8. Hyvelin JM, Howell K, Nichol A, Costello CM, Preston RJ, McLoughlin P. Inhibition of Rho-kinase attenuates hypoxia-induced angiogenesis in the pulmonary circulation. Circ Res 2005;97:185-191. (Pubitemid 41033475)
9. Wojciak-Stothard B, Tsang LY, Paleolog E, Hall SM, Haworth SG. Rac1 and RhoA as regulators of endothelial phenotype and barrier function in hypoxia-induced neonatal pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2006;290:L1173-L1182. (Pubitemid 43830862)
10. Fagan KA, Oka M, Bauer NR, Gebb SA, Ivy DD, Morris KG, McMurtry IF. Attenuation of acute hypoxic pulmonary hypertension in mice by inhibition of Rho-kinase. Am J Physiol Lung Cell Mol Physiol 2004;287:L656-L664. (Pubitemid 39249378)
11. Nagaoka T, Morio Y, Casanova N, Bauer N, Gebb S, McMurtry I, Oka M. Rho/Rho kinase signaling mediates increased basal pulmonary vascular tone in chronically hypoxic rats. Am J Physiol Lung Cell Mol Physiol 2004;287:L665-L672. (Pubitemid 39249379)
12. Roninson IB. Oncogenic functions of tumor suppressor p21 (Waf1/Cip1/Sdi1): association with cell senescence and tumor-promoting activities of stromal fibroblasts. Cancer Lett 2002;179:1-14. (Pubitemid 34195647)
13. Sandal T. Molecular aspects of the mammalian cell cycle and cancer. Oncologist 2002;7:73-81. (Pubitemid 34151110)
14. Yu L, Quinn DA, Garg HG, Hales CA. Gene expression of cyclin-dependent kinase inhibitors and effect of heparin on their expression in mice with hypoxia-induced pulmonary hypertension. Biochem Biophys Res Commun 2006;345:1565-1572. (Pubitemid 43817908)
15. Vidal A, Millard SS, Miller JP, Koff A. Rho activity can alter the translation of p27 mRNA and is important for RasV12-induced transformation in a manner dependent on p27 status. J Biol Chem 2002;277:16433-16440. (Pubitemid 34967655)
16. Mammoto A, Huang S, Moore K, Oh P, Ingber DE. Role of RhoA, mDia, and ROCK in cell shape-dependent control of the Skp2-p27kip1 pathway and the G1/S transition. J Biol Chem 2004;279:26323-26330. (Pubitemid 38798782)
17. Besson A, Gurian-West M, Schmidt A, Hall A, Roberts JM. p27Kip1 modulates cell migration through the regulation of RhoA activation. Genes Dev 2004;18:862-876. (Pubitemid 38529656)
18. Kanda T, Hayashi K, Wakino S, Homma K, Yoshioka K, Hasegawa K, Sugano N, Tatematsu S, Takamatsu I, Mitsuhashi T, et al. Role of Rho-kinase and p27 in angiotensin II-induced vascular injury. Hypertension 2005;45:724-729. (Pubitemid 40418372)
19. Loirand G, Guerin P, Pacaud P. Rho kinases in cardiovascular physiology and pathophysiology. Circ Res 2006;98:322-334.
20. Hales CA, Kradin RL, Brandstetter RD, Zhu YJ. Impariment of hypoxic pulmonary artery remodeling by heparin in mice. Am Rev Respir Dis 1983;128:747-751. (Pubitemid 13014131)
21. Hassoun PM, Thompson BT, Steigman D, Hales CA. Effect of heparin and warfarin on chronic hypoxic pulmonary hypertension and vascular remodeling in the guinea pig. Am Rev Respir Dis 1989;139:763-768. (Pubitemid 19084403)
22. Spence CR, Thompson BT, Janssens SP, Steigman DM, Hales CA. Effect of aerosol heparin on the development of hypoxic pulmonary hypertension in the guinea pig. Am Rev Respir Dis 1993;148:241.
23. Hassoun PM, Thompson BT, Hales CA. Partial reversal of hypoxic pulmonary hypertension by heparin. Am Rev Respir Dis 1992;145:193-196.
24. Joseph PAM, Garg HG, Thompson BT, Liu X, Hales CA. Influence of molecular weight, protein core and charge of native heparin fractions on pulmonary artery smooth muscle cells proliferation. Biochem Biophys Res Commun 1997;241:18-23. (Pubitemid 28033532)
25. Garg HG, Yu L, Hales CA, Toshihiko T, Tasneem I, Linhardt RJ. Sulfation pattern of heparin/heparan sulfate: effects on the proliferation of bovine pulmonary artery smooth muscle cells. Biochim Biophys Acta 2003;1639:225-231. (Pubitemid 37421429)
26. Benitz WE, Kelley RT, Anderson CM, Lorant DE, Bernfield M. Endothelial heparan sulfate proteoglycan. I. Inhibitory effects on smooth muscle cell proliferation. Am J Respir Cell Mol Biol 1990;2:13-14.
27. Khoury J, Langleben D. Heparin like molecules inhibit pulmonary vascular pericyte proliferation in vitro. Am J Physiol Lung Cell Mol Physiol 2000;279:L252-L261.
28. Kazi M, Lundmark K, Religa P, Gouda I, Larm O, Ray A, Swedenborg J, Hedin U. Inhibition of rat smooth muscle cell adhesion and proliferation by non-anticoagulant heparins. J Cell Physiol 2002;193:365-372. (Pubitemid 35265955)
29. Yu L, Quinn DA, Garg HG, Hales CA. Cyclin-dependent kinase inhibitor p27Kip1, but not p21WAF1/Cip1, is required for inhibition of hypoxia-induced pulmonary hypertension and remodeling by heparin in mice. Circ Res 2005;97:937-945. (Pubitemid 41552680)
30. Fasciano S, Patel RC, Handy I, Patel CV. Regulation of vascular smooth muscle proliferation by heparin: inhibition of cyclin-dependent kinase 2 activity by p27(kip1). J Biol Chem 2005;280:15682-15689. (Pubitemid 40616687)
31. Yu L, Quinn DA, Garg HG, Hales CA. Deficiency of the NHE1 gene prevents hypoxia-induced pulmonary hypertension and vascular remodeling. Am J Respir Crit Care Med 2008;177:1276-1284. (Pubitemid 351860938)
32. Rossman KL, Der CJ, Sondek J. GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors. Nat Rev Mol Cell Biol 2005;6:167-180. (Pubitemid 40215811)
33. Schmidt A, Hall A. Guanine nucleotide exchange factors for Rho GTPases: turning on the switch. Genes Dev 2002;16:1587-1609. (Pubitemid 34743321)
34. Aijaz S, D'Atri F, Citi S, BaldaMS, Matter K. Binding of GEF-H1 to the tight junction-associated adaptor cingulin results in inhibition of Rho signaling and G1/S phase transition. Dev Cell 2005;8:777-786. (Pubitemid 40585299)
35. Birukova AA, Adyshev D, Gorshkov B, Bokoch GM, Birukov KG, Verin AD. GEF-H1 is involved in agonist-induced human pulmonary endothelial barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 2006;290:L540-L548. (Pubitemid 43725099)
36. Krendel M, Zenke FT, Bokoch GM. Nucleotide exchange factor GEF-H1 mediates cross-talk between microtubules and the actin cytoskeleton. Nat Cell Biol 2002;4:294-301. (Pubitemid 34308855)
37. Mizuarai S, Yamanaka K, Kotani H. Mutant p53 induces the GEF-H1 oncogene, a guanine nucleotide exchange factor-H1 for RhoA, resulting in accelerated cell proliferation in tumor cells. Cancer Res 2006;66:6319-6326.
38. Zenke FT, Krendel M, DerMardirossian C, King CC, Bohl BP, Bokoch GM. p21-activated kinase 1 phosphorylates and regulates 14-3-3 binding to GEF-H1, a microtubule-localized Rho exchange factor. J Biol Chem 2004;279:18392-18400. (Pubitemid 38623255)
39. Callow MG, Zozulya S, Gishizky ML, Jallal B, Smeal T. PAK4 mediates morphological changes through the regulation of GEF-H1. J Cell Sci 2005;118:1861-1872. (Pubitemid 40723831)
40. Girgis RE, Mozammel S, Champion HC, Li D, Peng X, Shimoda L, Tuder RM, Johns RA, Hassoun PM. Regression of chronic hypoxic pulmonary hypertension by simvastatin. Am J Physiol Lung Cell Mol Physiol 2007;292:L1105-L1110. (Pubitemid 47084854)
41. McMurtry IF, Bauer NR, Fagan KA, Nagaoka T, Gebb SA, Oka M. Hypoxia and Rho/Rho-kinase signaling: lung development versus hypoxic pulmonary hypertension. Adv Exp Med Biol 2003;543:127-137. (Pubitemid 38183720)
42. Oka M, Homma N, Taraseviciene-Stewart L, Morris KG, Kraskauskas D, Burns N, Voelkel NF, McMurtry IF. Rho kinase-mediated vasoconstriction is important in severe occlusive pulmonary arterial hypertension in rats. Circ Res 2007;100:923-929. (Pubitemid 46555698)
43. Abe K, Tawara S, Oi K, Hizume T, Uwatoku T, Fukumoto Y, Kaibuchi K, Shimokawa H. Long-term inhibition of Rho-kinase ameliorates hypoxia-induced pulmonary hypertension in mice. J Cardiovasc Pharmacol 2006;48:280-285. (Pubitemid 46066832)
44. Li F, Xia W, Li A, Zhao C, Sun R. Long-term inhibition of Rho kinase with fasudil attenuates high flow induced pulmonary artery remodeling in rats. Pharmacol Res 2007;55:64-71. (Pubitemid 46108589)
45. Zhao L, Sebkhi A, Ali O, Wojciak-Stothard B, Mamanova L, Yang Q, Wharton J, Wilkins MR. Simvastatin and sildenafil combine to attenuate pulmonary hypertension. Eur Respir J 2009;34:948-957.
46. Fujishiro SH, Tanimura S, Mure S, Kashimoto Y, Watanabe K, Kohno M. ERK1/2 phosphorylate GEF-H1 to enhance its guanine nucleotide exchange activity toward RhoA. Biochem Biophys Res Commun 2008;368:162-167.
47. Kakiashvili E, Speight P, Waheed F, Seth R, Lodyga M, Tanimura S, Kohno M, Rotstein OD, Kapus A, Szászi K. GEF-H1 mediates tumor necrosis factor-alpha-induced Rho activation and myosin phosphorylation: role in the regulation of tubular paracellular permeability. J Biol Chem 2009;284:11454-11466.